Dec 6 (Reuters) - Immutep Ltd:
* IMMUTEP ANNOUNCES GMP MANUFACTURING PROCESS DEVELOPED FOR IMP761, A FIRST-IN-CLASS LAG-3 AGONIST FOR AUTOIMMUNE DISEASE Source text for Eikon: Further company coverage:
Dec 6 (Reuters) - Immutep Ltd:
* IMMUTEP ANNOUNCES GMP MANUFACTURING PROCESS DEVELOPED FOR IMP761, A FIRST-IN-CLASS LAG-3 AGONIST FOR AUTOIMMUNE DISEASE Source text for Eikon: Further company coverage: